Vanguard Personalized Indexing Management
MDGL icon

Vanguard Personalized Indexing Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Sell
1,356
-387
-22% -$198K 0.01% 1173
2026
Q1 		$912K Buy
1,743
+494
+40% +$236K 0.01% 978
2025
Q4 		$727K Buy
1,249
+160
+15% +$81.7K 0.01% 1061
2025
Q3 		$499K Buy
1,089
+105
+11% +$39.2K 0.01% 1243
2025
Q2 		$298K Buy
984
+21
+2% +$6.26K ﹤0.01% 1446
2025
Q1 		$319K Buy
963
+173
+22% +$56.8K ﹤0.01% 1311
2024
Q4 		$244K Buy
+790
New +$222K ﹤0.01% 1433
2024
Q3 		– Sell
-728
Closed -$204K – 1804
2024
Q2 		$204K Buy
+728
New +$173K ﹤0.01% 1447

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Personalized Indexing Management's MDGL Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 22% in Q2 2026, selling an estimated $198K and leaving 1,356 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1173.

Vanguard Personalized Indexing Management first reported a position in MDGL in Q2 2024 and has held it in 8 quarters since. The position peaked at $912K in Q1 2026. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Vanguard Personalized Indexing Management held 1,356 shares of Madrigal Pharmaceuticals worth $728K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 387 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $198K.
  • Madrigal Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1173 holding.
  • Vanguard Personalized Indexing Management first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Vanguard Personalized Indexing Management's Madrigal Pharmaceuticals position peaked at $912K in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.